GILEAD SCIENCES, INC.: cash and cash equivalents
Cash and cash equivalents for GILEAD SCIENCES, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All GILEAD SCIENCES, INC. financial histories
What this measure means
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2006-12-31 to 2022-12-31. The SEC response was captured on 2026-09-20.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2022-12-31 | 5,412,000,000 | USD | 2023-02-22 | 10-K · 0000882095-23-000007 |
| At date | 2021-12-31 | 5,338,000,000 | USD | 2023-02-22 | 10-K · 0000882095-23-000007 |
| At date | 2020-12-31 | 5,997,000,000 | USD | 2022-02-23 | 10-K · 0000882095-22-000007 |
| At date | 2019-12-31 | 11,631,000,000 | USD | 2021-02-25 | 10-K · 0000882095-21-000008 |
| At date | 2018-12-31 | 17,940,000,000 | USD | 2020-02-25 | 10-K · 0000882095-20-000006 |
| At date | 2017-12-31 | 7,588,000,000 | USD | 2019-02-26 | 10-K · 0000882095-19-000006 |
| At date | 2016-12-31 | 8,229,000,000 | USD | 2019-02-26 | 10-K · 0000882095-19-000006 |
| At date | 2015-12-31 | 12,851,000,000 | USD | 2019-02-26 | 10-K · 0000882095-19-000006 |
| At date | 2014-12-31 | 10,027,000,000 | USD | 2018-02-27 | 10-K · 0000882095-18-000008 |
| At date | 2013-12-31 | 2,113,000,000 | USD | 2017-02-27 | 10-K · 0000882095-17-000006 |
| At date | 2012-12-31 | 1,804,000,000 | USD | 2016-02-24 | 10-K · 0000882095-16-000039 |
| At date | 2011-12-31 | 9,884,000,000 | USD | 2015-02-25 | 10-K · 0000882095-15-000008 |
| At date | 2010-12-31 | 907,879,000 | USD | 2014-02-25 | 10-K · 0000882095-14-000013 |
| At date | 2009-12-31 | 1,272,958,000 | USD | 2013-02-27 | 10-K · 0000882095-13-000015 |
| At date | 2008-12-31 | 1,459,302,000 | USD | 2012-02-23 | 10-K · 0001193125-12-075335 |
| At date | 2007-12-31 | 968,086,000 | USD | 2011-02-28 | 10-K · 0001193125-11-050041 |
| At date | 2006-12-31 | 816,007,000 | USD | 2010-03-01 | 10-K · 0001193125-10-044753 |
Related financial histories
- GILEAD SCIENCES, INC.: total assets
- GILEAD SCIENCES, INC.: stockholders equity
- GILEAD SCIENCES, INC.: net income or loss
- GILEAD SCIENCES, INC.: operating cash flow
- GILEAD SCIENCES, INC.: capital expenditure payments
- GILEAD SCIENCES, INC.: revenue
- GILEAD SCIENCES, INC.: contract revenue excluding tax
- GILEAD SCIENCES, INC.: financing cash flow
- GILEAD SCIENCES, INC.: investing cash flow
- GILEAD SCIENCES, INC.: retained earnings or deficit
- GILEAD SCIENCES, INC.: basic weighted-average shares
- GILEAD SCIENCES, INC.: diluted weighted-average shares
- GILEAD SCIENCES, INC.: basic earnings per share
- GILEAD SCIENCES, INC.: diluted earnings per share
- GILEAD SCIENCES, INC.: income tax expense or benefit
- GILEAD SCIENCES, INC.: net property, plant and equipment
- GILEAD SCIENCES, INC.: share-based compensation expense
- GILEAD SCIENCES, INC.: operating income or loss
- GILEAD SCIENCES, INC.: current assets
- GILEAD SCIENCES, INC.: interest expense
- GILEAD SCIENCES, INC.: current liabilities
- GILEAD SCIENCES, INC.: current accounts payable
- GILEAD SCIENCES, INC.: goodwill carrying amount
- GILEAD SCIENCES, INC.: net finite-lived intangible assets
- GILEAD SCIENCES, INC.: net current accounts receivable
- GILEAD SCIENCES, INC.: common-stock repurchase payments
- GILEAD SCIENCES, INC.: net inventory
- GILEAD SCIENCES, INC.: selling, general and administrative expense
- GILEAD SCIENCES, INC.: research and development expense
Inspect the source
- Entity
- GILEAD SCIENCES, INC. / CIK 0000882095
- Captured
- 2026-09-20T05:01:55.429Z
- SEC response SHA-256
5703fd84d6e3d00697ac60bc3d7ded9306be2a9f36170a342858b8e6417506f0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000882095.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))